Articles in IPOs

Renaissance Capital

Diagnostics developer T2 Biosystems sets terms for $64 million IPO

T2 Biosystems, which is developing diagnostics tests that screen for sepsis and hemostasis, announced terms for its IPO on Monday. The Lexington, MA based company plans to raise $64 million by... Read >>

Renaissance Capital

Virgin America IPO takes flight as discount airline files to raise $115 million

Virgin America, a US based low cost airline founded by Richard Branson, filed on Monday with the SEC to raise up to $115 million in an initial public offering. The Burlingame, CA based company,... Read >>

Renaissance Capital

Independence Contract Drilling sets terms for $150 million IPO

Independence Contract Drilling, which operates six land drilling rigs contracted to US oil and gas E&Ps, announced terms for its IPO on Monday. The Houston, TX based company plans to raise... Read >>

Renaissance Capital

22 US IPOs planned for the week of Jul 28

The following IPOs are expected to price this week Atara Biotherapeutics ( ATRA ), a early stage biotech targeting muscle loss in patients with end stage renal disease, plans to raise $75... Read >>

Renaissance Capital

US IPO Pricing Recap: The crazy chicken flies while 8 IPOs trade down or flat

This week's 10 IPOs largely disappointed as 70% were forced to price below the proposed range and 80% closed the week up 1% or less. Before this week, only 36% of IPOs this year had first day... Read >>

Renaissance Capital

Chinese mobile game publisher iDreamSky Technology sets terms for $100 million IPO

iDreamSky Technology, a Chinese mobile game publisher with 100 million monthly active users, announced terms for its IPO on Friday. The Shenzhen, China based company plans to raise $100 million... Read >>

Renaissance Capital

Biotech Mapi-Pharma slashes range before IPO; valuation cut by 45%

Mapi Pharma, which is developing enhanced generic versions of marketed drugs such as Teva's Copaxone, lowered the proposed deal size for its upcoming IPO on Thursday. The Ness Ziona, Israel... Read >>

Renaissance Capital

Orion Engineered Carbons prices IPO at $18, well below the range

Orion Engineered Carbons, a global producer of the chemical additive carbon black used in industrial rubber, raised $351 million by offering 19.5 million shares (all secondary) at $18, well... Read >>

Renaissance Capital

Innocoll prices IPO at $9, below the range

Innocoll, which develops absorbable collagen drugs to treat pain, foot infections and adhesions, raised $59 million by offering 6.5 million ADSs (upsized from 5.4 million) at $9, below the range... Read >>

Renaissance Capital

Ocular Therapeutix prices IPO below the range at $13

Ocular Therapeutix, which develops eye therapies using a sustained release hydrogel platform, raised $65 million by offering 5 million shares at $13, below the range of $14 to $16. Ocular... Read >>

Displaying 1-10 of 2520
<< first < previous 1 2 3 4 5 50 100 150 200 250 last >>